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ABSTRACT 15 
The outer membrane (OM) of Gram-negative bacteria serves as a selective permeability 16 
barrier that allows entry of essential nutrients while excluding toxic compounds, including 17 
antibiotics. The OM is asymmetric and contains an outer leaflet of lipopolysaccharides (LPS) or 18 
lipooligosaccharides (LOS) and an inner leaflet of glycerophospholipids (GPL). We screened 19 
Acinetobacter baumannii transposon mutants and identified a number of mutants with OM 20 
defects, including an ABC transporter system homologous to the Mla system in E. coli. We 21 
further show that this opportunistic, antibiotic-resistant pathogen uses this multicomponent 22 
protein complex and ATP hydrolysis at the inner membrane to promote GPL export to the OM. 23 
The broad conservation of the Mla system in Gram-negative bacteria suggests the system may 24 
play a conserved role in OM biogenesis. The importance of the Mla system to Acinetobacter 25 
baumannii OM integrity and antibiotic sensitivity suggests that its components may serve as new 26 
antimicrobial therapeutic targets. 27 
 28 
INTRODUCTION 29 
Gram-negative bacteria are enveloped by two lipid bilayers, separated by an aqueous 30 
periplasmic space containing a peptidoglycan cell wall. The inner membrane (IM) is a symmetric 31 
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bilayer of glycerophospholipids (GPL), of which zwitterionic phosphatidylethanalomine (PE), 32 
acidic phosphatidylglycerol (PG), and cardiolipin (CL) are among the most widely distributed in 33 
bacteria (1). In contrast, the outer membrane (OM) is largely asymmetric and composed of an 34 
inner leaflet of GPL and an outer leaflet of lipopolysaccharide (LPS) or lipooligosaccharide 35 
(LOS) (2). The OM forms the first line of defense against antimicrobials by functioning as a 36 
molecular permeability barrier. The asymmetric nature of its lipid bilayer and the structure of 37 
LPS/LOS molecules facilitates barrier function, as the core region of LPS impedes the entry of 38 
hydrophobic molecules into the cell while the acyl chains within the bilayer also help to prevent 39 
the entry of many hydrophilic compounds (3). Although progress has been made in 40 
understanding many aspects of OM assembly ± including the discovery of an LPS transport 41 
system and the machinery for proper folding and insertion of outer membrane proteins (4, 5) ± 42 
little is known about the molecular mechanisms for transport of the GPLs necessary for OM 43 
formation and barrier function. 44 
Acinetobacter baumannii is an important cause of antibiotic-resistant opportunistic 45 
infections and has significant innate resistance to disinfectants and antibiotics. Similar to other 46 
Gram-negative opportunistic pathogens such as Pseudomonas aeruginosa and Klebsiella spp., 47 
individuals with breached skin or damaged respiratory tract mucosa are most vulnerable (6, 7). 48 
We performed a genetic screen to identify genes important for the OM barrier of A. baumannii. 49 
This led to the identification of an ABC (ATP-binding cassette) transporter complex that 50 
promotes GPL export to the OM. Transporter disruption attenuates bacterial OM barrier 51 
function, resulting in increased susceptibility of A. baumannii to a wide variety of antibiotics.  52 
The homologous system for E. coli has previously been termed Mla for its suggested role 53 
in the maintenance of outer membrane lipid asymmetry via the removal of GPL from the outer 54 
leaflet of the OM to the IM. While this is a reasonable hypothesis, there is not direct biochemical 55 
evidence that the Mla system functions to return GPL from the OM to the IM. In this work, we 56 
present evidence that the A. baumannii Mla system functions to promote GPL movement from 57 
the IM to the OM. This conclusion is based on the observation that newly synthesized GPLs 58 
accumulate at the IM of mla mutants, akin to how LPS molecules accumulate at the inner 59 
membrane in bacteria with mutations in the lpt genes encoding the LPS ABC transport system 60 
(5). Given the broad conservation of Mla in prokaryotic diderm organisms, the anterograde 61 
trafficking function of Mla might be exploited by a variety of species. 62 
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 63 
RESULTS 64 
A screen for activity of a periplasmic phosphatase identifies genes required for A. 65 
baumannii OM barrier function. 66 
We identified strains with mutations in genes required for maintenance of the 67 
Acinetobacter baumannii OM barrier by screening transposon mutants for the development of a 68 
blue colony phenotype on agar plates containing the chromogenic substrate BCIP-Toluidine 69 
(XP). Although A. baumannii carries an endogenous periplasmic phosphatase enzyme, colonies 70 
remain white on agar plates containing XP. We reasoned that lesions in genes necessary for the 71 
OM barrier function should result in a blue colony phenotype, as the XP substrate becomes 72 
accessible to the periplasmic enzyme (8, 9). Screening roughly 80,000 transposon-containing 73 
colonies for the blue colony phenotype yielded 364 blue colonies whose insertions were mapped 74 
to 58 unique genes (Supplemental File 1). We confirmed the results of the screen by assaying for 75 
OM-barrier defects using ethidium bromide (EtBr) and N-Phenyl-1-naphthylamine (NPN) 76 
uptake assays (10, 11). We also tested for resistance to antimicrobials, including trimethoprim, 77 
rifampicin, imipenem, carbenicillin, amikacin, gentamicin, tetracycline, polymyxin B, and 78 
erythromycin. Greater than 85% of the strains identified in the screen demonstrated decreased 79 
OM barrier function compared to wild type. Out of the 58 strains with transposon insertions, 23 80 
demonstrated OM permeability defects by NPN and EtBr uptake assays, and 49 out of 58 81 
resulted in increased sensitivity to two or more antibiotics compared to the parent strain, 82 
indicating that the screen identified lesions causing OM barrier defects leading to increased 83 
permeability to small charged and hydrophobic molecules, including commonly used antibiotics.   84 
 85 
The Mla system is necessary for A. baumannii OM integrity  86 
 Four mutants with a blue colony phenotype contained unique transposon insertions in the 87 
genetic loci A1S_3103 and A1S_3102, predicted to encode core components (mlaF and mlaE) of 88 
a multicomponent ABC transport system. These genes are within a five-gene operon that 89 
encodes for a conserved proteobacterial ABC transport system homologous to the E. coli mla 90 
system previously implicated in OM integrity (12). The A. baumannii operon includes: mlaF and 91 
mlaE, respectively predicted to encode the nucleotide-binding and transmembrane domains of an 92 
ABC transporter; mlaD, encoding a protein containing an IM-spanning domain and a predicted 93 
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periplasmic soluble domain; mlaC, encoding a soluble periplasmic protein; and mlaB, an 94 
additional gene predicted to encode a cytoplasmic sulfate transporter and anti-sigma factor 95 
antiagonist (STAS)-domain protein (Figure 1A). An additional putative OM lipoprotein is 96 
encoded on mlaA, or vacJ, which is clustered with the rest of the mla operon in some Gram-97 
negative bacteria, although it is at a different chromosomal location in A. baumannii. MlaA has 98 
been functionally associated with the rest of the Mla components in E. coli, as mutations in mlaA 99 
yield comparable phenotypes to mutations in other components of the system (8). 100 
Bioinformatic analysis predicts that the mlaC and mlaF genes respectively encode the 101 
soluble periplasmic component and cytoplasmic ATPase component of the ABC transport 102 
system, and we chose to focus on mutants of these genes for further experiments to elucidate the 103 
function of the mlaFEDCB operon. Chromosomal deletions were created by allelic exchange, 104 
and these mutations resulted in OM permeability defects as measured by EtBr uptake assays. We 105 
complemented the OM defect for the ¨mlaC and ¨mlaF deletion mutants by repairing the 106 
original deletion event in the chromosome and confirmed complementation of the observed 107 
permeability defect (Figure 1B). Deletions in mlaF and mlaC also rendered A. baumannii 108 
increasingly sensitive to a variety of antibiotics as determined by MIC measurements (Figure 109 
1D). Increased sensitivity to antibiotics whose uptake is not mediated by OM porins is consistent 110 
with a direct effect on the membrane component of the OM permeability barrier (13, 14). In 111 
addition to OM defects, the mla mutants display phenotypes that may correlate with OM stress, 112 
including increased production of extracellular carbohydrates as evidenced by crystal violet 113 
staining of pellicles following growth in broth culture (Figure 1 ± figure supplement 1A). These 114 
data indicate a role for Mla in the maintenance of the outer membrane barrier of A. baumannii. 115 
 116 
ATPase activity of MlaF is required for maintenance of the OM barrier of A. baumannii 117 
To exclude the possibility that the membrane defect was the result of the disruptive effect 118 
of a partially formed Mla protein complex, we engineered an enzymatically inactive ATPase 119 
component and expressed the defective enzyme from a plasmid. We reasoned that by expressing 120 
this allele in the wild type bacteria we could create a dominant-negative effect on Mla function. 121 
The cytoplasmic ATPase component of the Mla system, MlaF, contains the consensus sequence 122 
GxxxxGKT at residues 49-56, characteristic of a Walker A motif. Downstream residues 173-178 123 
contain the sequence LIMYDE, typical of a Walker B motif. The Walker motifs form highly 124 
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conserved structures critical for nucleotide binding and hydrolysis (15). The lysine residue of the 125 
Walker A motif is particularly essential for the hydrolysis of ATP. Mutations in this lysine 126 
residue are inhibited for nucleotide binding, and the mutated protein is rendered inactive (16). 127 
Additionally, ATPase mutants in the key lysine residue have been shown to have a dominant-128 
negative effect on ATP hydrolysis when co-expressed with their wild-type ATPase counterparts, 129 
as typical ABC transporters have a structural requirement for two functional nucleotide-binding 130 
proteins which dimerize upon substrate transport (17, 18).  131 
 Therefore, we created a version of the MlaF coding sequence with a leucine substitution 132 
of the Walker A lysine residue (MlaFK55L), and then cloned the mutated mlaF into the low-copy 133 
pMMBkan vector under control of the mlaF native promoter. We observed that expression of 134 
MlaFK55L in wild type A. baumannii had a dominant-negative effect on membrane permeability 135 
as measured by EtBr uptake (Figure 1C), and expression of MlaFK55L also resulted in increased 136 
exopolysaccharide production as demonstrated by increased staining by crystal violet (Figure 1 ± 137 
figure supplement 1B). Correspondingly, expression of MlaFK55L rendered A. baumannii more 138 
sensitive to a variety of antibiotics, resulting in reduced MICs when compared to A. baumannii 139 
expressing the empty pMMBkan vector (Figure 1D). Therefore, expression of a defective 140 
ATPase results in a dominant-negative mutant with a comparable phenotype to deletion of 141 
components of the mla operon. These results demonstrate a requirement for ATP hydrolysis by 142 
MlaF for the maintenance of OM barrier function in A. baumannii, and indicate that the 143 
phenotypes of deletion mutants were likely a result of a lack of transport function, rather than 144 
formation of a toxic incomplete membrane protein complex.   145 
 146 
Structure of the A. baumannii MlaBDEF complex  147 
The genetic arrangement and conservation of the components of this ATPase-containing 148 
transport complex indicated it was likely that the individual components formed a higher order 149 
protein structure. To define whether the Mla components form a stable protein complex, we 150 
expressed the entire operon (mlaFEDCB) from A. baumannii ATCC 17978 in E. coli with a 151 
carboxy-terminal hexahistidine tag on the MlaB component. Affinity purification of MlaB 152 
revealed three additional bands, with sizes corresponding to MlaF, MlaD, and MlaE (Figure 2 ± 153 
figure supplement 1) and confirmed by MALDI-TOF mass spectrometry analysis, indicating that 154 
these four proteins form a stable complex. We did not detect MlaC, suggesting it might interact 155 
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only transiently with the other components, consistent with results recently reported by Thong et 156 
al. (19). 157 
We next used cryo-electron microscopy to characterize the architecture of the A. 158 
baumannii MlaBDEF complex (abMlaBDEF). This complex is uniformly dispersed in vitreous 159 
ice (Figure 2 ± figure supplement 2A), and 2D classification demonstrated the presence of a 160 
range of views suitable for structure determination (Figure 2 ± figure supplement 2B). Following 161 
2D- and 3D-classification, we obtained a final dataset of ~ 14,000 particles with which we 162 
obtained a structure to a resolution of 8.7 Å (Figure 2 ± figure supplement 2D). The structure 163 
possesses significant visible features in agreement with the nominal resolution (Figure 2 ± figure 164 
supplement 2C). Based on the bioinformatically-predicted localization of individual proteins and 165 
work recently performed on the similar E. coli Mla complex (ecMlaBDEF) (19), we propose that 166 
MlaD localizes to the periplasmic side of the IM, MlaE forms the central transmembrane region, 167 
and MlaF and MlaB form the bottom layer on the cytoplasmic face of the IM with two visible 168 
hetero-dimers (Figure 2 ± figure supplement 2E). We note that the structure of ecMlaBDEF, at 169 
lower resolution, was reported recently (20). The overall features of both structures, solved 170 
independently, are identical, suggesting that they correspond to the correct structure for the 171 
complex. However, the limited resolution of the ecMlaBDEF complex structure did not allow 172 
modeling of its individual subunits, in contrast to the abMlaBDEF structure reported here. 173 
We note that a clear six-fold symmetry is present for the region of the map attributed to 174 
MlaD (Figure 2B), despite the fact that we only imposed a 2-fold symmetry averaging. This 175 
agrees with the proposed hexameric state of its E. coli homologue (ecMlaD) (19). We next 176 
modeled abMlaD, using an evolution restraints-derived structural model of ecMlaD (21) as a 177 
template, and used our previously-published EM-guided symmetry modeling procedure (22) to 178 
model its hexameric state. The obtained abMlaD hexameric model is at a low-energy minimum 179 
(Figure 2 ± figure supplement 3B) and fits the EM map density well (Figure 2B and Figure 2 ± 180 
figure supplement 4B). A crystal structure of the periplasmic domain of ecMlaD published 181 
recently (20) formed a crystallographic hexamer, suggesting that this corresponds to the native 182 
hexomeric arrangement for this domain. Our abMlaD hexameric model is very similar to the 183 
crystallographic ecMlaD structure (Figure 2 ± figure supplement 3C), supporting the proposed 184 
domain arrangement in the MlaBDEF complex. We note, however, that one region of density in 185 
the EM map is not accounted for by our MlaD hexamer model (Figure 2B). The localization of 186 
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this extra density suggests that it corresponds to a ~ 45 amino-acid insert present between strands 187 
4 and 5 of the abMlaD ȕ-sheet (Figure 2 ± figure supplement 4A). The role of this insert, 188 
uniquely found in the A. baumannii orthologue, is not known.  189 
We next modeled the structures of MlaB and MlaF and fitted their respective coordinates 190 
in the corresponding region of the EM map (Figure 2C and Figure 2 ± figure supplement 3A). 191 
For both proteins, most helices are well resolved, which allowed us to place the models 192 
unambiguously. We then compared the conformation of the ATPase MlaF to that of the maltose 193 
transporter ATPase MalK, which has been trapped in several conformations of the transporter; 194 
i.e. the inward-facing state, the pre-translocation state, and the outward-facing state (23, 24). 195 
Interestingly, the arrangement of MlaF clearly resembles the pre-translocation state of MalK 196 
(Figure 2D). This suggests that we have trapped a similar conformation of the abMlaBDEF 197 
complex. It is possible that MlaD and/or MlaF, for which there are no equivalent in other ABC 198 
transporters, stabilizes this conformation. Alternatively, it is possible that the presence of 199 
detergents, which were present to solubilize the complex, mimics the natural ligand in the 200 
WUDQVSRUWHU¶V active site. Finally, the transmembrane (TM) region of the map is well resolved, 201 
and density for the transmembrane (TM) helices can be clearly identified. We therefore modeled 202 
abMlaE, using an evolution restraints-derived structural model of ecMlaE (21) as a template, and 203 
fitted the obtained coordinates in the corresponding region of the map, with the orientation 204 
corresponding to the predicted topology. The resulting MlaE dimer model (Figure 2D) fits well 205 
to the EM map density (Figure 2 ± figure supplement 4C), and clearly corresponds to a closed 206 
transporter, with no solvent channel between the subunits. Interestingly, we also noted clear 207 
density for three TM helices that likely correspond to the MlaD N-terminal helices (Figure 3A). 208 
However, they lacked continuity, and we observed that only two form a direct interaction with 209 
MlaE. It is possible that this is due to heterogeneity in the orientation of MlaD relative to the rest 210 
of the complex. To verify this, we performed further 2D classification of the particles used for 211 
reconstruction (Figure 3B), which revealed a range of positions for the MlaD region relative to 212 
the rest of the complex. We therefore performed further 3D classification leading to a smaller 213 
dataset of ~ 8,000 particles. This produced a structure of lower resolution (~ 11.5 Å) but with the 214 
six MlaD N-terminal TM helices clearly visible (Figure 3B). While the periplasmic domain 215 
possesses 6-fold symmetry, the TM domains of MlaD do not appear symmetrical, with two 216 
forming close contacts with the density attributed to MlaE while the other four do not appear to 217 
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contact any other proteins. This observation likely explains the asymmetry of contacts between 218 
the dimeric MlaE and the hexameric MlaD. A higher-resolution structure will be required to 219 
determine if additional contacts are formed between the outward-facing loops of MlaE and the 220 
periplasmic domain of MlaD.  221 
 222 
Components of the Mla system interact directly with GPL  223 
The crystal structure of MlaC has been solved from Ralstonia solanacearum. The 224 
structure contains a single phosphatidylethanolamine molecule oriented such that the 225 
hydrophobic acyl chains are located inside the protein while the hydrophilic head group is 226 
exposed (25). More recently, the crystal structure for MlaC has been solved from E. coli and 227 
shown to bind lipid tails (20). As noted in previous work performed on the E. coli Mla system, 228 
this is strong evidence that the substrates of the Mla system are GPL (12). In order to confirm 229 
that the periplasmic components of the Mla pathway in A.baumannii interact with GPL, we 230 
purified the soluble domains of both MlaC and MlaD by expressing histidine-tagged proteins 231 
followed by Ni-affinity FPLC purification. After overnight dialysis of the proteins, we performed 232 
Bligh-dyer chloroform extraction on the purified proteins to isolate any bound GPL and analyzed 233 
the results by LC-MS/MS. GPL analysis revealed both phosphatidylglycerol and 234 
phosphatidylethanolamine of varying acyl chain lengths. This suggests the possibility that the 235 
periplasmic substrate binding components of the system may bind diacylated GPL molecules 236 
with limited polar head group specificity (Figure 4 ± figure supplement 1).  237 
Mla mutants have decreased abundance of outer membrane GPL 238 
Given the OM defect of mla PXWDQWVDVZHOODVWKHV\VWHP¶VDSSDUHQWGLUHFWDVVRFLDWLRQ239 
with GPL, we chose to further characterize the overall membrane GPL composition of the mla 240 
mutants. Previous work on the Mla system in E.coli has demonstrated an increase in hepta-241 
acylated lipid A in mla mutants, indicating activation of PagP that acylates GPL and lipid A in 242 
the outer leaflet of the OM in enterobacteria (12, 26). From this data it has been suggested that 243 
the system may serve to maintain lipid asymmetry within the OM, although it is well known that 244 
GPL displacement to the OM outer leaflet is a general reflection of chemical damage to the OM 245 
(27-29). However, biochemical analysis of the membrane GPL composition for mla mutants has 246 
not been published for any organism to our knowledgeVRZHVRXJKWWRDSSO\RXUODE¶VPHWKRGV247 
of GPL quantification to test the hypothesis of retrograde transport function. To determine 248 
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whether A. baumannii mla mutations cause changes in the membrane GPL concentration, GPL 249 
were extracted from inner and outer membrane fractions separated by density centrifugation. As 250 
can be seem on figure S11, density centrifugation results in nice separation of the outer and inner 251 
membranes of Acinetobacter baumannii, with the OM contain the vast majority of OmpA and 252 
the inner membrane containing all the NAPPH oxidase. Thin-layer chromatography (TLC) and 253 
electrospray-ionization time-of-flight mass spectrometry (ESI-MS) were used to qualitatively 254 
assess GPL composition from these well separated membrane fractions. TLC and ESI-MS 255 
indicated ǻmlaC A. baumannii had a dramatically decreased abundance of all major 256 
phospholipid species in the OM compared to wild type. (Figure 4A and Figure 4 ± figure 257 
supplement 2).  258 
To better analyze the differences in membrane GPL, we quantified GPL by normal phase 259 
liquid-chromatography collision-induced-dissociation mass spectrometry (LC-MS/MS). We 260 
quantified the ratio of individual GPL within each membrane by normalizing to an internal 261 
standard of known quantity. We then normalized the quantified GPL to the protein content of 262 
isolated IM and OM. Quantitative LC-MS/MS confirmed the overall reduction in outer 263 
membrane GPLs observed by ESI-MS and TLC, with the reduced levels observable across 264 
multiple GPL species for ǻmlaC mutants relative to wild type (Figure 4B).  Therefore, mutations 265 
in the components of the Mla system result in a decrease in OM GPL, whereas the retrograde 266 
transport hypothesis would predict an increase in OM GPL. Therefore, these results instead 267 
suggest a possible role for Mla in outward GPL trafficking.  268 
 269 
Mla mutants demonstrate an accumulation of newly synthesized GPL in the IM 270 
The overall decrease in outer membrane glycerophospholipids of A. baumannii mla 271 
mutants suggests that either the Mla system is functioning to deliver GPLs from the inner 272 
membrane to the outer membrane, or alternatively, mutations in the Mla system may disrupt the 273 
outer membrane in a manner that leads to the activation of outer membrane phospholipases, 274 
which then degrade GPL. Work performed on the Mla system in E.coli has demonstrated that 275 
disruption of genes in the Mla pathway results in activation of both the OM acyl-transferase 276 
PagP, which cleaves a palmitate moiety from GPL and transfers it to LPS and PG , creating a 277 
hepta-acylated LPS molecule and palmitoyl-PG and the OM phospholipase PldA (12, 28). A. 278 
baumannii has no known PagP enzyme but similar activity of the multiple predicted OM 279 
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phospholipases could account for the reduction in OM GPL as observed by TLC and quantitative 280 
mass spectrometry. Therefore, we designed a mass spectrometry-based assay to study 281 
intermembrane GPL transport using 13C stable isotope labeling (Figure 5 ± figure supplement 282 
1A), to better analyze the directionality of GPL transport by the Mla system between the 283 
bacterial membranes. When grown in culture with sodium acetate as the sole carbon source, 284 
many bacteria directly synthesize acetyl-CoA using the conserved enzyme acetyl-CoA synthase 285 
(30). Acetyl CoA, the precursor metabolite for fatty acid biosynthesis, is first converted to 286 
malonyl-CoA and enters the FasII (fatty acid biosynthesis) pathway that supplies endogenously 287 
synthesized fatty acids to macromolecules such as lipopolysaccharides, phospholipids, 288 
lipoproteins, and lipid-containing metabolites. By growing cultures in unlabeled acetate then 289 
³SXOVLQJ´ZLWK-13C acetate and analyzing separated membrane fractions from set time points, 290 
we can observe the flow of newly synthesized GPLs between the IM and OM of A. baumannii 291 
(Figure 5 ± figure supplement 1B) (26).  292 
Upon introducing the 2-13C acetate as the sole carbon source, 13C-labeled GPL were 293 
immediately synthesized in the bacterial cytoplasm.  We reasoned that continued growth in 13C 294 
acetate should result in a mixed pool of unlabeled and labeled IM GPL molecules. As the GPL 295 
are then fluxed from the IM to the OM, the likelihood that an individual GPL molecule is 296 
transported is directly proportional to the ratio of labeled to unlabeled GPL in the IM pool. As 297 
the bacteria continue to grow in 13C acetate, the ratio of labeled to unlabeled GPL in the IM will 298 
gradually increase as new GPL are synthesized and inserted in the IM. As such, the likelihood of 299 
transporting labeled GPL to the OM will also increase. A comparison of the ratios of labeled to 300 
unlabeled GPL in the IM and OM will thus reflect the efficiency of transport between the 301 
membranes, and analysis of transport in wild type A. baumannii will establish reference for 302 
transport efficiency with which to compare our mutants. Additionally, OM phospholipases, some 303 
of which may be activated upon membrane damage (31), will not distinguish between labeled 304 
and unlabeled GPL and therefore will not affect the ratio of labeled to unlabeled GPL obtained 305 
from this assay.  306 
 Membrane separation and analysis of wild type A. baumannii revealed near-identical 307 
rates-of-change between the two membranes in ratios of 13C-labeled to unlabeled GPLs, 308 
indicating that newly synthesized GPLs are transported and inserted into the OM at a rate 309 
equivalent to their rate of synthesis and assembly within the IM. Furthermore, the ratios of 310 
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labeled to unlabeled GPLs were nearly equal in the IM compared to the OM at the time points 311 
evaluated indicating that GPL transport likely occurs rapidly, consistent with earlier pulse-chase 312 
experiments performed in E. coli that estimate the half-life of translocation of various GPLs at 313 
between 0.5 and 2.8 min (32). By contrast, mutants in the Mla system accumulate newly 314 
synthesized GPLs in their IM at a greater rate than occurs in the OM as evidenced by the 315 
increasing disparity in the ratio of labeled to unlabeled GPLs between the IM and OM over time 316 
(Figure 5A). The discrepancy in ratios of labeled to unlabeled GPLs between the IM and OM of 317 
¨mlaF is apparent for PG and PE of varying acyl chain lengths corresponding to the most 318 
naturally abundant species C16:0/C16:0, C18:1/C18:1, or C16:0/C18:1 (Supplemental File 2).  319 
Further, the effects of MlaFK55L expression on GPL trafficking were similar to what was 320 
observed in the ¨mlaF strain (Figure 5B). Therefore, ATP hydrolysis by MlaF appears to be a 321 
requirement for extraction of these GPLs from the IM of A. baumannii for subsequent transport 322 
to the OM.  323 
 To better characterize the role of the periplasmic substrate binding component MlaC, we 324 
performed similar stable isotope pulse experiments to observe the flow of newly synthesized 325 
GPLs in the ¨mlaC strains. SWDEOHLVRWRSHH[SHULPHQWVRQ¨mlaC mutants reveal IM 326 
accumulation of newly synthesized GPLs similar to the result in ¨mlaF mutants (Figure 5 ± 327 
figure supplement 2A), indicating that in the absence of the periplasmic component GPLs are not 328 
efficiently removed from the IM by the remainder of the Mla system. We also sought to 329 
characterize the potential role of the putative OM-lipoprotein MlaA, which has been implicated 330 
as a component of the Mla system in E. coli. A chromosomal deletion strain of mlaA was created 331 
by allelic exchange, and complemented by expression of MlaA from a pMMB67EH-Kan 332 
plasmid. The results of the stable isotope pulse experiments in the ¨mlaA strain revealed results 333 
consistent with those obtained from ¨mlaC and ¨mlaF, in which the ratio of labeled to unlabeled 334 
GPL is consistently higher in the inner membrane than the outer membrane after one hour of 335 
exposure to 13C-acetate (Figure 5 ± figure supplement 2B and 2C). These results are consistent 336 
with a model in which the IM-localized ABC transporter complex MlaBDEF first transfers GPLs 337 
to the periplasmic binding protein MlaC, which then transports GPL to the OM, whereupon 338 
MlaA facilitates GPL insertion into the OM.  339 
 340 
DISCUSSION 341 
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We performed a screen to identify A. baumannii proteins that are essential for its OM 342 
barrier that led to the identification of an ABC transport system whose ATPase activity maintains 343 
OM barrier function. IM and periplasmic components of this system can be purified, bind GPLs, 344 
and assemble into a defined protein complex with significant symmetry, indicating that this 345 
system could function to transport GPLs from the IM to the OM. Consistent with the possibility 346 
that Mla functions as an anterograde transporter, the OM of mutants show an overall reduction of 347 
GPL along with an excess accumulation of newly synthesized GPL on the IM. Therefore, these 348 
results lead us to propose that the function of the A. baumannii Mla system is the trafficking of 349 
GPL from the IM, across the periplasm, for delivery to the outer membrane (Figure 6). 350 
According to this model, ATP hydrolysis by MlaF provides the initial energy to extract GPL 351 
from the IM, while the substrate binding components MlaD and MlaC take up lipids for delivery 352 
to the OM. It has been observed by van Meer and colleagues that complete extraction of GPLs 353 
from the membrane bilayer requires a Gibbs free energy of ~100 kJ/mol (33, 34), whereas ATP 354 
contains just 30 kJ/mol of energy. To account for the energy difference, a hydrophobic acceptor 355 
molecule is proposed to allow the lipids to fully dissociate from the rest of the ABC transporter 356 
and facilitate complete removal from the bilayer. The GPL-binding component, MlaD, contains 357 
an IM spanning domain and is shown here, and in orthologous systems, to be in complex with 358 
the MlaE and MlaF proteins within the IM (20, 35). The close association of MlaD with the outer 359 
leaflet of the IM may allow it to extract lipids from the IM by hydrophobic interaction with the 360 
acyl chains after ATP hydrolysis by MlaF. Subsequent trafficking across the periplasm then 361 
involves the periplasmic GPL binding protein MlaC, which likely accepts GPL from MlaD and 362 
then carries them to the OM. We note however the observed effect of mlaC deletion on GPL 363 
accumulation in the IM, while statistically significant for most of the analyzed diacyl-364 
glycerophospholipids, appears to be less than that of deletion of the ATPase component (Figure 365 
5C), suggesting that while MlaC may participate in transfer to the OM, there may be redundant 366 
mechanisms by which the IM complex can transport or remove IM GPL in the absence of MlaC. 367 
While the precise mechanism of GPL insertion into the OM is not yet known, work performed 368 
on the E.coli Mla system has shown that MlaC interacts with both the IM MlaFEDB complex, as 369 
well as with the putative OM lipoprotein MlaA, and our results support a role for MlaA in the 370 
function of the overall Mla system and delivery of GPL to the OM. 371 
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In this work, we designed a method to monitor lipid transport between Gram-negative 372 
bacterial membranes using stable 13C isotope labeling. We considered the possibility of loss of 373 
GPL from the outer membrane due to outer membrane vesicle formation or more likely, by the 374 
possible increased activation of outer membrane phospholipases. Both would have the effect of 375 
removing GPL from the outer membrane and would result in lower GPL levels in the outer 376 
membrane of mla mutants. Neither of these mechanisms would operate specifically on either 377 
labeled or unlabeled lipids. We understood the decrease in outer membrane GPL to be 378 
insufficient evidence of an anterograde transport function for mla, and for this reason we 379 
developed the stable isotope assay to control for these possibilities. The stable isotope assay 380 
gives insight into whether these results are due simply to mislocalization or degradation of outer 381 
membrane GPL, or if they can in fact be attributed to deficient anterograde GPL transport. This 382 
is because the peak intensity of each newly synthesized, C13-labeled GPL is normalized to the 383 
corresponding unlabeled version of that GPL species with each sample injected into the LC-384 
MS/MS. The result is a ratio of labeled to unlabeled GPL for every membrane sample. With C13-385 
acetate as the sole carbon source, we observe a gradual increase in the ratio of labeled GPL 386 
relative to unlabeled GPL over time. In wild type bacteria, these ratios for the inner and outer 387 
membranes track closely over time, which indicates that under these conditions GPL transport 388 
from the inner to the outer membrane occurs quite rapidly. In mla mutants the ratio is both higher 389 
and typically increases at a greater rate in the inner membrane. Phospholipases and budding 390 
outer membrane vesicles will not distinguish between labeled and unlabeled GPL species, and so 391 
will not impact the ratios obtained with this assay.  392 
Our results using this assay are consistent with the Mla system functioning as an 393 
anterograde GPL transporter, however they do not exclude the possibility of a dual role for Mla 394 
components in the maintenance of OM lipid asymmetry. Previous work performed on the 395 
orthologous Mla system in E.coli has been interpreted to suggest that the function of the system 396 
is to remove GPL from the outer leaflet of the OM for retrograde transport back into the 397 
cytoplasm based on the observation that E.coli mla mutants likely contain GPLs on the outer 398 
leaflet of the OM. (12, 36). This proposed function was inferred from the observation that gene 399 
deletions resulted in an increased activation of the OM-phospholipase enzymes PagP and 400 
OMPLA, suggesting an increased amount of GPL in the outer leaflet of the OM (12). The 401 
interpretation of retrograde transport function was also based on the existence of an orthologous 402 
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system in plant chloroplasts that transports lipids from the endoplasmic reticulum (ER) into the 403 
organelle. Many plants require this retrograde transport function because certain lipids in the 404 
chloroplast thylakoid membrane derive from GPL originating in the ER (37).  However, since 405 
Gram-negative bacteria synthesize GPL within the IM, retrograde transport of GPL would only 406 
be necessary for the recycling of GPL mislocalized to the OM outer leaflet. Although this is a 407 
reasonable inference based on data available at the time, we would point out that the 408 
directionality of transport by the E. coli Mla system had not been thoroughly probed 409 
experimentally using membrane analysis or with a functional assay of the type performed here. It 410 
is conceivable that the import function of the orthologous chloroplast TGD system is a result of 411 
adaptation to the intracellular environment, the system in this case having evolved to aid in the 412 
transfer of GPL from the nearby ER to the chloroplast. Furthermore, while it is possible that the 413 
Mla system in E. coli serves a different primary function than in A. baumannii, we demonstrate 414 
here that both complexes possess a similar architecture, pointing to a conserved function. The 415 
outer membrane defect phenotypes observed in E. coli mla mutants might also be explained by a 416 
disruption of OM structure stemming from decreased concentrations of OM GPL, leading to 417 
activation of the PagP enzyme. It is well established that for E. coli, GPL displacement to the 418 
OM outer leaflet and subsequent activation of these enzymes reflects OM instability and can be 419 
achieved by chemical disruption of the bilayer (27-29). It may be the case that the OM of E. coli 420 
mla mutants contain GPL in the outer leaflet, but the possibility remains that OM GPL can flip 421 
into the outer leaflet under conditions of OM damage resulting from an imbalance of LPS-to-422 
GPL ratios, along with perhaps the corresponding disruption of OM proteins. However, final 423 
determination of the directionality of GPL transport by the Mla system in E.coli and other 424 
organisms will require intermembrane transport studies similar to what has been done here for A. 425 
baumannii, along with studies similar to those performed for the Lpt LPS transport system for 426 
which molecular transfer of LPS from molecule to molecule of the Lpt system is functionally 427 
defined.  428 
Following the introduction of the retrograde transport model for Mla function into the 429 
existing literature, a number of studies have examined the phenotypic effects of Mla disruption 430 
in various organisms. In a recent study in PNAS, Powers and Trent  first obtained A. baumannii 431 
deficient in lipooligosaccharide (LOS) by selection in the presence of polymyxin B (38). They 432 
then performed an evolution experiment, passaging the strains in cultures containing polymyxin 433 
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B over 120 generations, at which point they observed significantly improved growth in the 434 
populations. These evolved populations were also observed to have increased resistance to 435 
antibiotics including vancomycin, bacitracin, and daptomycin, and to appear more 436 
morphologically consistent relative to the unevolved strains when observed microscopically. 437 
Whole genome sequencing of the evolved strains revealed mutations in mla genes in seven of the 438 
10 evolved populations. They also observed frequent disruptions in pldA, as well as in other 439 
envelope genes. To further study these effects, they then introduced clean deletions of mlaE and 440 
pldA to ATCC 19606, and selected for LOS-deficient bacteria by plating on polymyxin B. These 441 
double mutants demonstrated improved growth and resistance to antibiotics but continued to 442 
display altered cellular morphology. The authors present their data as evidence in support of Mla 443 
as a retrograde transport system, and assume that a lack of removal of GPL from the outer leaflet 444 
is promoting the OM barrier. We would point out that lacking in their data is examination of the 445 
membrane glycerophospholipid (GPL) profile in their LOS-deficient mutants. It is assumed by 446 
the authors that mla and pldA mutations have the effect of stabilizing a symmetric outer 447 
membrane produced in the absence of LOS by allowing GPL to fill in the outer leaflet, resulting 448 
in improved growth and antibiotic resistance. Given that the data suggests that Mla and PldA are 449 
selected against when LOS is absent, examination of the outer membrane GPL content might 450 
KDYHVXSSRUWHGWKHDXWKRUV¶FRQFOXVLRQVLILWUHYHDOHGDQLQFUHDVHLQ*3/LQmla and pldA 451 
mutants. Absent such data, it is not obvious to us that the authors have sufficiently ruled out 452 
alternative explanations for their observed phenomena. For example, we would question the 453 
mechanisms regulating the homeostasis of both the inner and outer membranes and the entire 454 
periplasmic space in the absence of LOS. The authors acknowledge earlier work that observed an 455 
increase in expression of mla genes upon initial loss of LOS in 19606 (39, 40). Genes in the mla 456 
pathway were shown to have an up to 7.5-fold increase in gene expression upon loss of LOS. 457 
Powers and Trent assert that the function of Mla is deleterious in the absence of LOS, but 458 
perhaps what is deleterious is the profound upregulation of mla expression in the absence of 459 
LOS, combined with an active PldA. If Mla is an anterograde transporter, we can imagine this 460 
might create a situation in which GPL are rapidly removed from the inner membrane and then 461 
degraded in the outer membrane in excess of what the cell can support and limiting both of these 462 
processes together simply allows the cell to achieve a new homeostasis. Understanding of the 463 
myriad processes regulating bacterial outer membrane assembly and integrity remains limited 464 
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even when LOS is present, and so interpreting results such as these as providing direct evidence 465 
of function may exceed the limits of the data.  466 
The gene for MlaA, the proposed OM component, is at a different chromosomal location 467 
from the remainder of the mla operon. Recent structural studies on MlaA have revealed that 468 
MlaA forms a ring-shaped structure localized the inner leaflet of the OM, and have shown it to 469 
form stable complexes with the outer membrane proteins OmpF and OmpC (41). The proposed 470 
structure of MlaA in the OM supports the argument that MlaA is involved in removal of GPL 471 
from the outer leaflet, and it is suggested that GPL from the outer leaflet travel through a pore in 472 
MlaA where they are received by MlaC, yet our data reveals that A. baumannii ¨mlaA mutants 473 
are defective in delivery of GPL from the IM to the OM. These data can be reconciled by a 474 
model in which MlaA functions both to remove mislocalized GPL from the outer leaflet of the 475 
OM, and additionally serves to facilitate delivery of GPL to the OM by MlaC, perhaps by 476 
enabling MlaC localization to the surface of the inner leaflet. By this model, mutations in MlaA 477 
will be phenotypically similar to mutations in other components of the Mla system, and we 478 
would expect to observe a decreased rate of anterograde GPL transport. We would here point out 479 
that while previous work has implicated the Mla system in the maintenance of OM lipid 480 
asymmetry through observation of increased activity of PagP, the role of the MlaFEDB complex 481 
and MlaC in retrograde GPL transport has previously only been inferred from homology to the 482 
chloroplast TGD system. It is established that cellular mechanisms exist in Gram-negative 483 
bacteria to resist stressful conditions that lead to OM disruption. For example, OM 484 
phospholipase enzymes, such as PldA, are activated under conditions of membrane stress to 485 
digest GPL in the outer leaflet of the OM, as high levels of GPL in the outer leaflet destabilize 486 
the OM barrier function. The model of retrograde GPL transport by the Mla system proposes that 487 
growing cells expend cellular energy in the form of ATP in order to transport undigested GPL 488 
from the OM, across the periplasm, and back into the IM, at which point some of those same 489 
molecules will be transported back to the OM by an unknown mechanism. However, the 490 
available data points most clearly to a model of anterograde GPL transport by MlaFEDB and 491 
MlaC, facilitated in some way by MlaA.  492 
The first three genes of the mla operon ± comprising an ATPase, permease, and substrate-493 
binding components of the ABC transporter complex ± are conserved in Mycobacteria spp, 494 
Actinobacteria, and chloroplasts, while the entire five-gene operon appears to be conserved in 495 
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Gram-negative bacteria (42). Given the conservation of the system across Gram-negative 496 
species, our results may shed light on a generalized mechanism contributing to OM biogenesis. 497 
Additionally, we have here demonstrated that the function of this ABC transport system is 498 
crucial for maintaining the integrity of the A. baumannii OM. The fact that mla mutations are 499 
tolerated, and that levels of OM GPL are reduced but not abolished, suggests the intriguing 500 
possibility of additional undiscovered mechanisms of GPL delivery to the OM. Also of interest is 501 
the potential role of the increased exopolysaccharide observed upon disruption of the Mla 502 
system. It is possible this exopolysaccharide plays a partially compensatory role in A. baumannii 503 
resulting from decreased OM GPL, given that recent work has shown that A. baumannii 504 
exopolysaccharides can contribute to antibiotic resistance, likely through improved barrier 505 
function (43). 506 
 The progression towards a more complete understanding of intermembrane GPL 507 
transport and OM barrier function should ultimately have relevance in the development of novel 508 
drug targets to undermine emerging antibiotic resistance in Gram-negative pathogens.  The 509 
emergence of antibiotic resistant Gram-negative bacteria for which few or no antibiotics are 510 
available therapeutically is an important medical concern. This issue is typified by current 511 
isolates of A. baumannii that can only be treated with relatively toxic colistin antibiotics. This 512 
has led many individuals and agencies to propose the development of single agent antimicrobials 513 
which could be used for organisms such as A. baumannii and P. aeruginosa that have significant 514 
antibiotic resistance. Therefore, work furthering the understanding of the OM barrier could lead 515 
to the development of drugs which target the barrier and allow the therapeutic use of many 516 
current antibiotics.  517 
 518 
MATERIALS AND METHODS 519 
Key Resources Table 
 
   
Reagent type 
(species) or resource Designation Source or reference Identifiers Additional information 
gene (Acinetobacter 
baumannii) mlaC NA 
Genbank Accession: 
AKA30172.1   
gene (A. baumannii) mlaF NA Genbank Accession: AKA30169.1   
gene (A. baumannii) mlaE NA Genbank Accession: AKA30170.1   
gene (A. baumannii) mlaD NA Genbank Accession: AKA30171.1   
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gene (A. baumannii) mlaB NA Genbank Accession: AKA30173.1   
gene (A. baumannii) mlaA NA Genbank Accession: AKA32955.1   
gene (A. baumannii) phoU NA Genbank Accession: AKA33305.1   
strain, strain 
background (A. 
baumannii) 
Acinetobacter 
baumannii ATCC 
17978 
Reference: 
PIECHAUD, D., M. 
PIECHAUD, AND L. 
SECOND. 1951. Etude 
de 26 souches de 
Moraxella iwoffi. Ann. 
Inst. Pasteur 80:97-
99; PMCID: 
PMC251972. Source: 
ATCC 
GenBank 
ACCESSION: 
CP000521 
  
genetic reagent (A. 
baumannii) 
ATCC 17978 ¨SKR8  
This paper   
Chromosomal deletion in ATCC 17978 
by allelic exchange using pEX2tetRA 
vector 
genetic reagent (A. 
baumannii) ¨POD) 
This paper   
Chromosomal deletion in ATCC 17978 
by allelic exchange using pEX2tetRA 
vector 
genetic reagent (A. 
baumannii) ¨mlaC 
This paper   
Chromosomal deletion in ATCC 17978 
by allelic exchange using pEX2tetRA 
vector 
genetic reagent (A. 
baumannii) ¨mlaA 
This paper   
Chromosomal deletion in ATCC 17978 
by allelic exchange using pEX2tetRA 
vector 
antibody anti-OmpA (rabbit polyclonal) This paper   
Made to purified OmpA by GenScript 
Biotech Corp (1:1000) 
recombinant DNA 
reagent pMarKT (plasmid) This paper   
Progenitors: C9 Himar (PCR), TetRA 
from Tn10 (PCR), pACYC184, pBT20.  
recombinant DNA 
reagent pEX2tetRA (plasmid) This paper   Progenitors:  tetRA (PCR), pEXG2 
recombinant DNA 
reagent pMMBkan (plasmid) This paper   
Kanamycin resistance marker inserted 
at DraI site of pMMB67EH 
recombinant DNA 
reagent 
pMMBkan:MlaF 
(plasmid) This paper   pMMBKan expressing mlaF 
recombinant DNA 
reagent 
pMMBkan:MlaFK55L 
(plasmid) This paper   
pMMBKan expressing Walker box 
mutant of mlaF 
recombinant DNA 
reagent 
pET28a:MlaFEDCB-
His (plasmid) This paper   
pET28a expressing MlaFEDCB with C-
terminal HISX6 tag on MlaB. 
recombinant DNA 
reagent pET15b-mlaC-SD-His (plasmid) 
This paper 
  
pET15b expression vector containing 
MlaC soluble domain with C-terminal 
HisX6 tag. 
recombinant DNA 
reagent pET15b-mlaD-SD-His (plasmid) 
This paper 
  
pET15b expression vector containing 
MlaD soluble domain with C-terminal 
HisX6 tag. 
chemical compound, 
drug 2-13C acetate 
Cambridge Isotope 
Laboratories, Inc.     
chemical compound, 
drug BCIP-Toluidine (XP) Gold Biotechnology B-500-10   
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chemical compound, 
drug 
N-Phenyl-1-
naphthylamine (NPN) Sigma Aldrich 104043-500G   
chemical compound, 
drug NADH Sigma Aldrich 606-68-8   
chemical compound, 
drug 
CCCP (Carbonyl 
cyanide 3-
chlorophenylhydrazon
e) Sigma-Aldrich C2759-1G   
software, algorithm 
MotionCorr2 
Zheng et al, 2016, 
Nature Methods. 
PMID: 28250466   
Dr. Agard Lab, University of CA San 
Francisco 
software, algorithm 
CTFFIND4 
Rohou & Grigorieff, 
2015, J Struct Biol. 
PMID: 26278980   
Dr. Grigorieff Lab, University of MA 
Medical Center 
software, algorithm 
Appion 
Lander et al, 2009, J 
Struct Biol. PMID: 
19263523   
Dr. Carragher Lab, The Scripps 
Research Institute 
software, algorithm 
Relion 2 
Scheres, 2012, J Mol 
Biol. PMID: 22100448   
Dr. Scheres Lab, MRC Lab of 
Molecular Biology 
software, algorithm 
EMAN2 
Tang et al, 2007, J 
Struct Biol. PMID: 
16859925   Dr. Ludtke Lab, Blue Mountain College 
software, algorithm 
Chimera 
Pettersen et al, 2004, J 
Comput Chem. PMID: 
15264254   
UCSF Resource for Biocomputing, 
Visualization, and Informatics 
software, algorithm 
Modeller 
Webb & Sali, 2016, 
Current Protocols in 
Bioinformatics. PMID: 
27322406   
Dr. Sali Lab, University of CA San 
Francisco 
software, algorithm 
Rosetta 
DiMaio et al, 2011, 
PLoS One. PMID: 
21731614   Dr. Baker Lab, University of WA 
 520 
Bacterial strains: 521 
Transposon mutagenesis and subsequent chromosomal deletions of mla genes were performed in 522 
Acinetobacter baumannii ATCC 17978.  523 
 524 
A Mariner-based transposon vector for use in Acinetobacter baumannii: 525 
To perform transposon mutagenesis a Mariner-based transposon vector was designed for use in 526 
Acinetobacter baumannii ATCC 17978. The new transposon vector, derived from pBT20, 527 
termed pMarKT, contains an outward facing pTac promotor as well as a selectable kanamycin 528 
resistance marker followed by an omega terminator within the Mariner arm sites (44). The 529 
plasmid backbone contains the Mariner transposase gene C9 Himar, a tetRA resistance marker 530 
from Tn10, a p15A origin from pACYC184, and an oriT site for mobilization. The plasmid was 531 
constructed by PCR of select fragments followed by restriction digest and ligation of the cleaved 532 
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ends. The new transposon vector was confirmed by restriction digest and partial sequencing.  533 
 534 
Transposon mutagenesis:  535 
Initial mutagenesis revealed that many hits occurred in the high affinity phosphate uptake 536 
transcriptional repressor phoU (A1S_0256). Subsequent rounds of mutagenesis were conducted 537 
on an ATCC 17978 phoU chromosomal deletion strain, and plated on high phosphate media to 538 
reduce the background level of cleavage of the chromogenic substrate. Chromosomal deletions 539 
were performed by allelic exchange using a pEX2tetRA vector, which was created by insertion 540 
of the tetRA tetracycline resistance marker from Tn10 into the pEXG2 plasmid (45). Roughly 541 
1000bp regions upstream and downstream of the genes of interest were amplified for 542 
homologous recombination with the ATCC 17978 chromosome. Sucrose was used to counter-543 
select against cells retaining the pEX2tetRA backbone, and deletions were confirmed by PCR. 544 
Complementation of deletions was accomplished by repairing the original deletion in the 545 
chromosome, again using the pEX system and allelic exchange. 546 
Donor E. coli containing the pMarKT transposon vector were suspended in LB broth to 547 
an OD600 of 40 and mixed with an equal volume of the recipient A. baumannii suspended to 548 
OD600 of 20. 50 µL aliquots of this mixture were then plated in spots on a dried LB agar plate 549 
and incubated for 2 h at 37 °C (44). Each 50 µL spot resulted in about 80,000 colonies of A. 550 
baumannii containing Mariner transposon insertions. The mutants were plated on LB agar 551 
containing 1X M63 salts, 50 µg/mL kanamycin, 30 µg/mL chloramphenicol, and 40 µg/mL XP 552 
substrate. Plates were incubated for at least 36 h at 30 °C to allow for the appearance of the blue 553 
color from cleavage of the XP substrate. Sequencing of the transposon insertions was adapted 554 
from the method described in Chun et. al. (46), including semi-arbitrary two-step PCR 555 
amplification of transposon regions followed by sequencing. 556 
 557 
Ethidium bromide uptake assay: 558 
Bacteria were grown in 5 mL LB cultures to mid-log OD600 (0.3-0.6), then spun down and 559 
normalized in PBS to OD600 0.2. Prior to measurement, CCCP was added at 200 µM to inhibit 560 
the activity of efflux pumps. Ethidium bromide was added immediately prior to measurement to 561 
final concentration of 1.2 µM in 200 µL total reaction volume. Permeability was assessed using a 562 
PerkinElmer EnVision 2104 Multilabel Reader using a 531 nm excitation filter, 590 nm emission 563 
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filter, and a 560 nm dichroic mirror. Readings were taken every 15 s for 30 min with samples 564 
assessed in triplicate in a Greiner bio-one 96-well flat bottom black plate.  565 
 566 
MIC measurements: 567 
MICs were determined in 96-well microtiter plates using a standard two-fold broth dilution 568 
method of antibiotics in LB broth. The wells were inoculated with 104 bacteria per well, to a 569 
final well volume of 100 PL, and plates were incubated at 37 °C with shaking unless stated 570 
otherwise. Experiments were performed thrice using two technical replicates per experiment. 571 
MICs were interpreted as the lowest antibiotic concentration for which the average OD600 across 572 
replicates was less than 50% of the average OD600 measurement without antibiotic. 573 
 574 
Crystal violet assay for exopolysaccharide production: 575 
Strains were inoculated to OD600 0.05 and grown overnight at 37 °C in 2 mL LB broth with 576 
shaking in glass tubes. The next day, liquid was carefully decanted and the tubes left to dry for 2 577 
h at 37 °C. Pellicles were stained with the addition of 0.1% crystal violet, then gently washed 578 
three times in dH2O. Crystal violet was solubilized in a 80:20 solution of ethanol:acetone and 579 
UHDGDWQP3YDOXHVZHUHGHWHUPLQHGIURPD6WXGHQW¶VW-test over three biological replicates 580 
per sample. 581 
 582 
MlaFEDB protein expression and purification: 583 
The mlaFEDCB operon from the genome of A. baumannii ATCC 17978 was subcloned into the 584 
pET-28a vector (Novagen, US) with a hexahistidine (-6HIS) tag fused at the C-terminus of the 585 
MlaB protein. The nucleotide sequence of the operon was confirmed using DNA sequencing. 586 
The plasmid was transformed into E. coli RosettaBlue strain. Cells were grown at 37 °C in LB 587 
medium until the cell density reached an OD600 of 1.0. The temperature was then reduced to 16 588 
&EHIRUHLQGXFWLRQZLWKP0LVRSURS\Oȕ-D-thiogalactoside (IPTG). After growth at 16 °C for 589 
18 h, cells were harvested by using centrifugation at 4,200 g. Cells were resuspended in ice-cold 590 
buffer A (20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5% (v/v) glycerol) and subjected to three 591 
runs of homogenization at 10,000±15,000 psi using Avestin EmulsiFlex-C3 high pressure 592 
homogenizer (Avestin, Ottawa, Ontario, Canada). The homogenate was centrifuged at 17,000 g 593 
for 10 min at 4 °C, and then the supernatant was ultra-centrifuged at 100,000 g for 60 min. The 594 
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membrane fraction was resuspended in buffer A supplemented with 1% (w/v) dodecyl-ȕ-d-595 
maltopyranoside (DDM) and was slowly stirred for 1 h at 4 °C. After another ultra-centrifugation 596 
at 100,000 g for 30 min, the supernatant was collected and loaded on 2 ml of Ni2+-597 
nitrilotriacetate affinity resin (Ni-NTA from Qiagen, Germany) pre-equilibrated with buffer A 598 
supplemented with 5 mM imidazole and 0.025% (w/v) DDM. After incubating for 1 h, the resin 599 
was washed with 50 ml buffer A supplemented with 20 mM imidazole and 0.025% (w/v) DDM. 600 
The protein sample was eluted with 10 ml elution buffer containing buffer A, 300 mM 601 
imidazole, and 0.025% (w/v) DDM, and was concentrated to 0.5 ml. The concentrated protein 602 
sample was then loaded onto a Superdex-200 column (10/30, GE Healthcare, US) pre-603 
equilibrated with 20 mM Hepes (pH 7.0) 150 mM Nacl 0.025% DDM. Peak fractions were 604 
collected and the pooled protein sample was concentrated to 1 mg/ml.  605 
 606 
Cryo-EM sample preparation, data acquisition and image processing: 607 
Purified Mla complex at ~1 mg/ml was applied to glow-discharged holey grids, blotted for 6 s, 608 
and plunged in liquid ethane using a Vitrobot (FEI). Images were acquired on a FEI Tecnai G2 609 
F20 200 kV Cryo-TEM equipped with a Gatan K-2 Summit Direct Electron Detector camera 610 
with a pixel size of 1.26 Å/pixel. 500 micrographs were collected using Leginon (47) spanning a 611 
defocus range of -1 to -2 µm.  612 
 613 
Movie frames were aligned with MotionCorr2 (48) and the defocus parameters were estimated 614 
with CTFFIND4 (49). 333 high-quality micrographs were selected by manual inspection, from 615 
which ~55,000 particles were picked with DOG in Appion (50). Particle stacks were generated in 616 
Appion using a box size of 200 pixels. Several successive rounds of 2D and 3D classification 617 
were performed in Relion 2 (51, 52) using an initial model generated by Common Lines in 618 
EMAN2 (53) leading to a final stack of ~ 14,000 particles for 3D structure refinement in Relion. 619 
 620 
Structure modeling and docking in the EM density: 621 
The structures of MlaB and MlaF were modeled using the threading server Phyre (54) based on 622 
the structures of the anti-sigma factor antagonist tm1081 (PDB ID 3F43, 18% sequence identity 623 
to MlaB) and the ABC ATPase ABC2 (PDB ID 1OXT, 36% sequence identity to MlaF) 624 
respectively. Two copies of each structural model were positioned in their putative location 625 
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within the EM map using Chimera (55) and their position was optimised using the Fit to EM 626 
map option. The abMlaD and abMlaE structures were modelled on ecMlaD and ecMlaE 627 
structural models deposited in the Gremelin database (21), using Modeller. For abMlaD, the N-628 
terminal TM helix and the insert region were modelled ab initio using the Rosetta suite (56) and 629 
positioned in their putative localisation in Chimera. The MlaD hexamer, as well as the MlaE 630 
dimer, were modelled with Rosetta using a EM-guided symmetry modelling approach described 631 
previously (22). The final model was refined with Rosetta. 632 
Membrane Isolation and Separation 633 
Cells were resuspended in 20 mL of 0.5 M sucrose, 10 mM Tris pH 7.8, 75 µg freshly prepared 634 
lysozyme (Roche 10837059001), and 20 mL of 0.5 mM EDTA, and kept on ice with gentle 635 
stirring for 20 min. Samples were homogenized (Avestin EmulsiFlex-C3) and spun down at 636 
17,000 g for 10 min to removed un-lysed cells prior to ultracentrifugation. Membranes were spun 637 
down using a Ti45 Beckman rotor at 100,000 g for 1 h and then added to the top of a sucrose 638 
gradient. IM and OM were separated by 18-hour ultracentrifugation using a SW-41 rotor in a 639 
Beckman Coulter Optima L90X ultracentrifuge. Spheroplast formation and sucrose gradient 640 
separation of IM and OM was adapted from a method by Osborn et. al  (57) by use of a defined 641 
73%-53%-20% sucrose gradient as described in Dalebroux et. al. (58). Our sucrose gradients 642 
contain three distinct concentrations of sucrose, and inner and outer membranes separate into 643 
distinct bands that are collected individually (Figure 5 ± figure supplement 3F). To limit any 644 
potential mixing of the membranes, the inner membrane is collected from the top of the tube 645 
while the outer membrane is collected by puncturing the bottom of the tube and allowing the 646 
bottom band to be collected. The purity of membrane separation by this method was confirmed 647 
by NADH assay and by Western blotting for the A. baumannii OM-localized OmpA protein, 648 
with 10 µg of total protein loaded into each lane as measured by Bradford protein assay (Figure 5 649 
± figure supplement 3).  650 
 651 
GPL extraction and TLC: 652 
GPLs from isolated membranes were extracted using a 0.8:1:2 ratio of water : chloroform : 653 
methanol as per the method of Bligh and Dyer (59). Two-dimensional TLC was performed using 654 
silica gel 60 plates and immersion in Solvent System A (60:25:4 CHCl3:CH3OH:H2O), followed 655 
by Solvent System B (80:12:15:4 CHCl3:CH3OH:CH3COOH:H2O) in the orthogonal direction. 656 
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 657 
MlaC and MlaD protein purification and GPL extraction: 658 
Primers were designed to amplify the mlaC gene of ATCC 17978, excluding the signal sequence 659 
for export from the cytoplasm, and the periplasmic domain of mlaD of ATCC 17978, excluding 660 
the membrane-spanning domain. These fragments were cloned into pET29b and expressed with 661 
a carboxy-terminal hexahistidine (-6HIS) tag in BL21 E. coli with 2 h induction. Cells were 662 
pelleted and resuspended in Tris-buffered saline containing 10% glycerol (TBSG) and protease 663 
inhibitor cocktail (Roche, Complete EDTA-free). Cells were lysed by homogenization (Avestin) 664 
and ultracentrifuged at 100,000 g for 1 h to spin down membranes. The supernatants were then 665 
applied to a 5 mL-HiTrap(TM) Chelating HP Ni-affinity column pre-loaded with 0.1 M NiSO4666 
DQGHTXLOLEUDWHGZLWK7%6*7KHSURWHLQVZHUHHOXWHGIURPWKHFROXPQXVLQJ)3/&$NWDE\667 
DSSO\LQJDVWHSZLVHJUDGLHQWRIP0P0DQGILQDOO\P0LPLGD]ROHIRUSURWHLQ668 
HOXWLRQ(OXWLRQZDVPRQLWRUHGE\89-DEVRUSWLRQDWQP7KH0OD&-DQG0OD'-FRQWDLQLQJ669 
IUDFWLRQVZHUHWKHQIXUWKHUSXULILHGE\LQMHFWLQJLQWRD+L/RDGPO-6XSHUGH[70670 
SUHSDUDWLYHJUDGHVL]H-H[FOXVLRQFROXPQHTXLOLEUDWHGLQ7%6*XVLQJDIORZUDWHRIP/PLQ671 
7KHSXULW\RIWKHFROOHFWHGSURWHLQIUDFWLRQVZDVFRQILUPHGE\6'6SRO\DFU\ODPLGHJHO672 
HOHFWURSKRUHVLV3URWHLQVZHUHGLOXWHGWRPJP/DQGGLDO\]HGRYHUQLJKWLQ/7%6*DW4 °C 673 
ZLWKVWLUULQJGPLs were extracted from 1 mg each of purified proteins MlaC and MlaD by the 674 
method of Bligh and Dyer and analyzed by LC-MS/MS as previously described. 675 
 676 
LC-MS/MS: 677 
Retention of PG, CL, PE, and Lyso-CL was achieved at a flow rate of 0.3 mL/min using mobile 678 
phase A [CHCl3/CH3OH/NH4OH (800:195:5 v/v/v)] and mobile phase B 679 
[CHCl3/CH3OH/NH4OH (600:340:5 v/v/v)]. The chromatography method used is a three-step 680 
gradient as described in the SI Materials and Methods of Dalebroux et al. (26). The samples were 681 
run on an Agilent Zorbax Rx-SIL silica column (2.1x100mm, 1.8-Micron) using an Agilent 682 
HPLC autosampler. Mass spectrometry was performed using an AB Sciex API4000 Qtrap with 683 
multiple reaction monitoring (MRM). The identities of the major GPLs present in the A. 684 
baumannii membrane were predicted by parent ion scans.  685 
 686 
Stable isotope assay development:  687 
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The Q1/Q3 transitions of glycerolphospholipids from cells grown in 2-13C acetate were 688 
determined using a Thermo Orbitrap LTQ. The integrated peak areas of both 13C-labeled and 689 
unlabeled GPLs from the AB Sciex API4000 Qtrap were used to calculate the ion-current ratios 690 
for each GPL species. The ratio of labeled GPL for each unique species can be calculated based 691 
on the following equation: 692 
  693 
Rlab = Ri - Rb (60)  694 
  695 
Where Ri is the ion-current ratio of labeled GPL to unlabeled GPL within the sample and Rb is 696 
the ion-current ratio of samples before the administration of the tracer, 13C-acetate, and 697 
represents the natural background abundance of the stable isotope species within the bacterial 698 
membrane.  Rlab approximates the molar ratio of labeled species to unlabeled species (nlab/nun) 699 
according to the equation (nlab/nun) = [Ri-Rb]/k, where k is the molar response factor of the 700 
instrument and is ideally equal to unity (60).  701 
 702 
To demonstrate that OM phospholipases will not distinguish between labeled and unlabeled GPL 703 
and therefore will not affect the ratio of labeled to unlabeled GPL obtained from this assay, we 704 
compared ratios of labeled and unlabeled GPL from wild type A. baumannii and deletion 705 
mutants in pldA. Bacteria were grown carrying either the empty pMMB::kan vector, or 706 
expressing the Walker box mutant MlaFK55L. Accumulation of newly synthesized GPL was 707 
observed in those strains expressing MlaFK55L when compared to the vector control, across 708 
various species of GPL. Of strains expressing the vector control, on average 51.84% ± 1.07% 709 
and 52.07% ± 1.23% of newly synthesized PG C16:0/18:1 appeared on the inner membrane of 710 
ZLOGW\SHDQG¨pldA, respectively, after one hour incubation with 13C acetate, while 66.33% ± 711 
1.23% and 62.60% ± 1.70% of newly synthesized PG C16:0/18:1 accumulated at the inner 712 
PHPEUDQHVRIZLOGW\SHDQG¨pldA expressing MlaFK55L. In vector controls strains, 48.53% ± 713 
1.37% and 51.01% ± 0.55% of newly synthesized PG C16:0/16:0 appeared on the inner 714 
PHPEUDQHRIZLOGW\SHDQG¨pldA, respectively, after one hour incubation with 13C acetate, 715 
while 62.98% ± 1.01% and 60.41% ± 1.25% of newly synthesized PG C16:0/16:0 accumulated 716 
DWWKHLQQHUPHPEUDQHVRIZLOGW\SHDQG¨pldA expressing MlaFK55L. In vector controls strains, 717 
50.17% ± 1.31% and 50.49% ± 1.15% of newly synthesized PE C16:0/18:1 appeared on the 718 
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LQQHUPHPEUDQHRIZLOGW\SHDQG¨pldA, respectively, while 60.14% ± 0.93% and 62.06% ± 719 
1.07% of newly synthesized PE C16:0/18:1 accumulated at the inner membranes of wild type 720 
DQG¨pldA expressing MlaFK55L. 721 
 722 
Stable isotope GPL analysis and culture conditions: 723 
Cultures of A. baumannii ATCC 17978 were grown in M63 media containing 5 mM sodium 724 
acetate and 4 mM MgCl2 to OD600 0.4, then washed and resuspended in media containing 5 mM 725 
2-13C sodium acetate (Cat. No. CLM-381-0, Cambridge Isotope Laboratories, Inc.). Membrane 726 
fractions were isolated from both wild type and mla mutant A. baumannii at simultaneous time 727 
points, and GPL were extracted and assessed using previously established LC-MS/MS methods 728 
with additional MRM values to account for the increased m/z ratios of 13C-labeled GPL. MRMs 729 
were selected to account for PG and PE having acyl chains of either C16:0/16:0, C16:0/18:1, and 730 
C18:1/18:1 as these were determined by total ion scan MS to be the predominant species of PG 731 
and PE GPL. Pulse experiments were performed at least twice for each mutant.  732 
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  953 
LEGENDS 954 
 955 
Figure 1. Disruption of the Mla system results in an altered outer membrane barrier. (A) 956 
Genomic organization of the A. baumannii mlaFEDCB operon and its predicted products. 957 
Triangles indicate the position of four independent transposon insertions, isolated in a screen for 958 
genes involved in outer membrane integrity. (B) Ethidium bromide uptake assay of outer 959 
PHPEUDQHSHUPHDELOLW\RI¨mla mutants and complemented strains. A.U., arbitrary units. Lines 960 
shown depect the average of three technical replicates. (C) Ethidium bromide uptake assay of 961 
outer membrane permeability following plasmid-based expression of MlaF, compared to its 962 
dominant negative version, MlaFK55L. Lines shown depict the average of three technical 963 
replicates. (D) Minimum inhibitory concentration (MIC) of select antibiotics in A. baumannii. 964 
*Indicates wild type A. baumannii containing pMMB plasmid constructs, and cultures grown 965 
ZLWKWKHDGGLWLRQRINDQDP\FLQȝJP/WRPDLQWDLQSODVPLGVDQGȝ0,37*IRULQGXFWLRQ 966 
 967 
Figure 1 ± figure supplement 1. Disruption of the Mla system leads to an increase in 968 
exopolysaccharide production. (A) Quantification of crystal violet staining from mla deletion 969 
mutants. Error bars represent ± s.d. for biological replicates (n = 3). (B) Quantification of crystal 970 
violet staining following plasmid expression of MlaF compared to its dominant negative version, 971 
MlaFK55L. Error bars represent ± s.d. for biological replicates (n = 3).  972 
 973 
Figure 1 ± figure supplement 2. Phase microscopy images of wild type and mla mutant A. 974 
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baumannii. Images were collected from cultures grown to mid-log (OD600 0.4-0.6) growth 975 
phase from wild type (A), mlaA (B), mlaC (C), and mlaF (D) deletion mutants of A. baumannii. 976 
 977 
Figure 2. Structure of the abMlaBDEF complex. (A) Cryo-EM map of abMlaBDEF (grey), 978 
with structural models for MlaD, MlaB and MlaF (in magenta, cyan and green respectively) 979 
docked at their putative location, as viewed from the side and bottom. The density for most 980 
helices is clearly resolved. (B-D) Cartoon representation of the MlaD hexamer (B), the MlaB-981 
MlaF hetero-tetramer (C), and the MlaE dimer (D) region of the MlaBDEFab atomic model . (E) 982 
Comparison of the MlaF domain arrangement in the EM map to that of the Maltose transporter 983 
ATPase MalK. The two chains of MlaD (in light and dark green) superimpose well to those of 984 
MalK (in cyan and dark blue) in the pre- translocation conformation (left, PDB ID: 4KHZ), 985 
while a clear rotation is observed compared to the ATP-bound outward-facing conformation 986 
(right, PDB ID: 4KI0). 987 
 988 
Figure 2 ± figure supplement 1. Mla components copurify following protien expression. 989 
SDS-PAGE analysis of proteins copurified with hexahistidine-tagged MlaB (-His6). Band 990 
identities were assigned based on MS. 991 
 992 
Figure 2 ± figure supplement 2. Cryo-EM structure of the abMlaBDEF complex. (A) 993 
Representative electron micrograph region of frozen-hydrated MlaBDEF complex. The scale bar 994 
is in white at the bottom. (B) Representative reference-free 2D class averages of abMlaBDEF, 995 
generated using Relion, illustrating the various views observed. (C) Cryo-EM map of the Gpt 996 
complex, shown in two orientations corresponding to the two last classes shown in B. (D) The 997 
FSC curve for the MlaBDEF structure is shown in black, with the gold-standard resolution 998 
definition of 0.143% indicated with a red dotted line. The nominal resolution for this structure is 999 
8.7 Å. (E) The regions of density attributed to the periplasmic domain of MlaD, the TM domains 1000 
of MlaD and MlaE, and to MlaB and MlaF are in pink, yellow, cyan and green respectively. 1001 
 1002 
Figure 2 ± figure supplement 3. Modeling of the abMlaD hexamer. (A) Multiple alignment of 1003 
MlaD sequences from various gram-negative human pathogens. The secondary structure for 1004 
ecMlaD is shown at the top. The position of the abMlaD insert is indicated. (B) Result of the all-1005 
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atom refinement step for the MlaD hexameric model. The energy of each model is plotted versus 1006 
the RMSD relative to the initial model and color-coded for the fit to the EM map density. (C) 1007 
Cartoon representation of our abMlaD hexameric model (magenta), superimposed to the 1008 
crystallographic ecMlaD hexamer structure (grey).  1009 
 1010 
Figure 2 ± figure supplement 4. Close-up view of the MlaB, MlaD, MlaE and MlaF models 1011 
in the abMlaBDEF cryo-EM map. (A) Region of the density corresponding to a MlaD 1012 
monomer, with the corresponding atomic model in magenta. The density of the N-terminal helix 1013 
is well resolved, as well as that of the A. baumannii-specific insert. (B) Region of the density 1014 
corresponding to a MlaF-MlaB hetero-dimer, with the corresponding atomic models in green and 1015 
cyan respectively, shown from two different angles. Density for helices are well defined for most 1016 
of the model. (C) Region of the density corresponding to a MlaE monomer, with the 1017 
corresponding atomic model in yellow. 1018 
 1019 
Figure 3. Localization of the 6 TM helices from MlaD. (A) lateral section of the abMlaBDEF 1020 
EM map, with the MlaE model in yellow. Density attributed to the MlaD N-terminal helices are 1021 
indicated with a red star. (B) 2D classes generated from the set of particles used to generate the 1022 
MlaBDEFab structure, corresponding to side views. A range of orientations for the periplasmic 1023 
domain is observed. (C) Structure of MlaBDEFab, generated using a subset of the most 1024 
homogenious ~ 8,000 particles. Some features of the map shown in Figure 3C are not present, 1025 
but the overall structure is similar. Six well- defined helices in the central TM region are visible. 1026 
(D) Sections along the vertical axis, corresponding to the three red lines shown in B, is shown on 1027 
the left. The six- fold axis of MlaD is visible in the periplasmic region, but this breaks down in 1028 
the TM region, where the six helices are asymmetric. An angular representation of the six helices 1029 
is represented on the right. 1030 
 1031 
Figure 3 ± figure supplement 1. Comparison of the MlaBDEFab and MalBDEFec complex. 1032 
The map of MlaBDEFab (this study) is shown in grey, overlaid to that of MlaBDEFec (ekiert et 1033 
al.) in yellow, aligned in the cytosolic domains density. The overall architecture of both 1034 
complexes are similar, however MlaD appears offset by ~ 20 O in the A. baumannii complex, 1035 
compared to the E.coli complex. It remains to be determined if this corresponds to a difference 1036 
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between species, or if the two structures were obtained in different states of substrate binding 1037 
and/or nucleotide hydrolysis. 1038 
 1039 
Figure 42XWHUPHPEUDQHJO\FHURSKRVSKROLSLGOHYHOVDUHUHGXFHGLQ¨mlaC mutant. (A) 1040 
Identification of inner and outer membrane phospholipids of wild type A. baumannii DQG¨mlaC 1041 
using 2D thin-layer chromatography. PE, phosphatidylethanolamine; PG, phosphatidylglycerol; 1042 
CL, cardiolipin. (B) LC-MS/MS quantification of isolated inner and outer membrane 1043 
glycerophospholipids. Error bars indicate ± s.e.m. (n = 3).  1044 
 1045 
Figure 4 ± figure supplement 1. Purified periplasmic components of the Mla system remain 1046 
bound to glycerophospholipids. (A) Chromatogram of LC-MS/MS of glycerophospholipids 1047 
extracted from purified MlaC. Peaks were identified based on MS and elution time. PG, 1048 
phosphatidylglycerol. PE, phosphatidylethanolamine. (B) Chromatogram of LC-MS/MS of 1049 
glycerophospholipids extracted from purified MlaD soluble domain. 1050 
 1051 
Figure 4 ± figure supplement 2. Deletion of mlaC results in a reduction in levels of outer 1052 
membrane glycerophospholipids. Total ion scan of isolated outer membranes of A. baumannii 1053 
DQG¨POD&7\SLFDOPHPEUDQHJO\FHURSKRVSKROLSLGVIDOOZLWKLQWKHP]UDQJHRI-1500. 1054 
 1055 
Figure 5. Newly synthesized glycerophospholipids accumulate at the inner membrane of 1056 
Mla mutants. (A) LC-MS/MS quantification of 13C labelled/unlabeled glycerophospholipids in 1057 
isolated membrane fractions over time after growth in 2-13&DFHWDWHLQ¨mlaF and 1058 
complemented strain. Facet labels on the right indicate the specific glycerophospholipid species 1059 
analyzed and the acyl chain length. PG, phosphatidylglycerol; PE, phosphatidylethanolamine. 1060 
Shown is representative data from repeated experiments. (B) LC-MS/MS quantification of 13C 1061 
labelled/un- labeled glycerophospholipids in isolated membrane fractions following plasmid-1062 
based expression of MlaF compared to its dominant negative version, MlaFK55L. Facet labels on 1063 
the right indicate the specific glycerophospholipid species analyzed and the acyl chain length. 1064 
PG, phosphatidylglycerol; PE, phosphatidylethanolamine. Shown is representative data from 1065 
repeated experiments. (C) Relative proportion of newly synthesized GPL on IM and OM after 1066 
one hour growth in 2-13C acetate. Error bars represent ± s.d. (n = 2). Statistical analyses 1067 
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SHUIRUPHGXVLQJD6WXGHQW¶Vt test. p-Value: *, p < 0.05; **, p < 0.01. 1068 
 1069 
Figure 5 ± figure supplement 1. A stable isotope assay of glycerophospholipid transport 1070 
from the inner membrane to the outer membrane. (A) Schematic showing an example of the 1071 
shift in mass-to-charge ratio (m/z) of glycerophospholipids (GPL) following growth in 2-13C 1072 
acetate. (B) A schematic illustrating the rationale of the stable isotope assay: (1) Newly 1073 
synthesized 13C-labeled GPL, shown here in red, are first inserted into the inner membrane (IM) 1074 
following synthesis; (2) the likelihood that a given GPL that is trafficked from the IM to the OM 1075 
will be labeled is proportional to the ratio of labeled to unlabeled GPL in the IM; (3) a 1076 
comparison of the ratios of labeled to unlabeled GPL in the inner and outer membranes will 1077 
therefore reflect the efficiency of GPL transport. 1078 
 1079 
Figure 5 ± figure supplement 2. Newly synthesized glycerophospholipids accumulate at the 1080 
inner membrane of MlaA mutants. (A) LC-MS/MS quantification of 13C labelled/unlabeled 1081 
glycerophospholipids in isolated membrane fractions over time after growth in 2-13C acetate in 1082 
¨POD&DQGFRPSOHPHQWHGVWUDLQ)DFHWODEHOVRQWKHULJKWLQGLFDWHWKHVSHFLILF1083 
glycerophospholipid species analyzed and the acyl chain length. PG, phosphatidylglycerol; PE, 1084 
phosphatidylethanolamine. Shown is representative data from repeated experiments. (B) LC-1085 
MS/MS quantification of 13C labelled/unlabeled glycerophospholipids in isolated membrane 1086 
fractions over time after growth in 2-13&DFHWDWHLQ¨POD)DQGFRPSOHPHQWHGVWUDLQ)DFHWODEHOV1087 
on the right indicate the specific glycerophospholipid species analyzed and the acyl chain length. 1088 
PG, phosphatidylglycerol; PE, phosphatidylethanolamine. Shown is representative data from 1089 
repeated experiments. (C) Relative proportion of newly synthesized GPL on IM and OM after 1090 
one hour growth in 2-13C acetate. Error bars represent ± s.d. (n = 2). Statistical analyses 1091 
SHUIRUPHGXVLQJD6WXGHQW¶VWWHVWS-Value: *, p < 0.05; **, p < 0.01. 1092 
 1093 
Figure 5 ± figure supplement 3. Confirmation of inner and outer membrane separation. 1094 
(DFKODQHFRQWDLQVJWRWDOSURWHLQDVPHDVXUHGE\%UDGIRUGSURWHLQDVVD\$ܤ-OmpA 1095 
Western blot of separated membranes analyzed in Figure 4%ܤ-OmpA Western blot of 1096 
separated membranes analyzed in Figure 5$&ܤ-OmpA Western blot of separated membranes 1097 
analyzed in Figure 5%'ܤ-OmpA Western blot of separated membranes analyzed in Figure 1098 
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5C. (E) Coomasie stained SDS-protein gel of representative isolated membrane samples 1099 
alongside BioRad Precision Plus Protein Standard. (F) Separation of inner and outer membranes 1100 
into distinct bands by 3-step sucrose gradient. (G) NADH assay for enzymatic activity of inner 1101 
membrane.  1102 
 1103 
Figure 6. The multicomponent Mla system transports glycerophospholipids from the inner 1104 
membrane to the outer membrane of A. baumannii. A schematic of glycerophospholipid 1105 
transport to the Gram-negative bacterial outer membrane by the Mla system.  1106 
 1107 
Supplemental File 1: Results of transposon mutagenesis screen for genes involved in outer 1108 
membrane barrier function in ATCC 17978 1109 
 1110 
Supplemental File 2: Accumulation of newly synthesized glycerophospholipids in A. 1111 
baumannii inner and outer membranes 1112 
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Fig. 1. Disruption of the Mla system results in an altered outer membrane barrier. (A) Genomic organization of the A. baumannii mlaFEDCB operon and its predicted 
products. Triangles indicate the position of four independent transposon insertions, isolated in a screen for genes involved in outer membrane integrity. (B) Ethidium bromide 
XSWDNHDVVD\RIRXWHUPHPEUDQHSHUPHDELOLW\RI¨mla mutants and complemented strains. A.U., arbitrary units. Lines shown depect the average of three technical replicates. (C) 
Ethidium bromide uptake assay of outer membrane permeability following plasmid-based expression of MlaF, compared to its dominant negative version, MlaFK55L. Lines shown 
depict the average of three technical replicates. (D) Minimum inhibitory concentration (MIC) of select antibiotics in A. baumannii. *Indicates wild type A. baumannii containing 
pMMB plasmid constructs, and cultures grown with the addition of kanamycin (25 µg/mL) to maintain plasmids and 50 µM IPTG for induction. 
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Figure 1 - figure supplement 1. Disruption of the Mla system leads to an increase in exopolysaccharide produc-
tion. (A) Quantification of crystal violet staining from mla deletion mutants. Error bars represent ± s.d. for biological 
replicates (n = 3). (B) Quantification of crystal violet staining following plasmid expression of MlaF compared to its 
dominant negative version, MlaFK55L. Error bars represent ± s.d. for biological replicates (n = 3).
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Figure 1 - figure supplement 2. Phase microscopy images of wild type and mla mutant A. baumannii. Images were collected from cultures grown to mid-log (OD600 
0.4-0.6) growth phase from wild type (A), mlaA (B), mlaC (C), and mlaF (D) deletion mutants of A. baumannii.  
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Fig. 2. Structure of the abMlaBDEF complex. (A) Cryo-EM map of abMlaBDEF (grey), with structural models for MlaD, MlaB and MlaF (in magenta, cyan and green respectively) 
docked at their putative location, as viewed from the side and bottom. The density for most helices is clearly resolved. (B-D) Cartoon representation of the MlaD hexamer (B), the 
MlaB-MlaF hetero-tetramer (C), and the MlaE dimer (D) region of the MlaBDEFab atomic model . (E) Comparison of the MlaF domain arrangement in the EM map to that of the Maltose 
transporter ATPase MalK. The two chains of MlaD (in light and dark green) superimpose well to those of MalK (in cyan and dark blue) in the pre- translocation conformation (left, PDB ID: 
4KHZ), while a clear rotation is observed compared to the ATP-bound outward-facing conformation (right, PDB ID: 4KI0). 
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components copurify following 
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analysis of proteins copurified with 
hexahistidine-tagged MlaB (-His6). 
Band identities were assigned based 
on MS.
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Figure 2 - figure supplement 2. Cryo-EM structure of the abMlaBDEF complex. (A) Representative electron micrograph region of frozen-hydrated MlaBDEF complex. The scale bar is in white at the bottom. (B) Representative 
reference-free 2D class averages of abMlaBDEF, generated using Relion, illustrating the various views observed. (C) Cryo-EM map of the Gpt complex, shown in two orientations corresponding to the two last classes shown in B. 
(D) The FSC curve for the MlaBDEF structure is shown in black, with the gold-standard resolution definition of 0.143% indicated with a red dotted line. The nominal resolution for this structure is 8.7 Å. (E) The regions of density 
attributed to the periplasmic domain of MlaD, the TM domains of MlaD and MlaE, and to MlaB and MlaF are in pink, yellow, cyan and green respectively. 
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                                                   TT  TT     TT            TTT                                         Escherichia  
 1       10        20        30         40        50        60        70        80                                      
Escherichia            VG F      A                    Y   A F               GV  G V             V                                    T E   I LLA LL AL V LKA V T L   NIGGLKAR PV I   V R I LD T  TL I.MQ KKN IW A F C AN TSIRTEP. T Y T D S S G V AD T PK YLPR E E...............................
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Figure 2 - figure supplement 3. Modeling of the abMlaD hexamer. (A) Multiple alignment of MlaD sequences from various gram-negative human pathogens. The secondary structure for ecMlaD is shown at the top. The position of 
the abMlaD insert is indicated. (B) Result of the all-atom refinement step for the MlaD hexameric model. The energy of each model is plotted versus the RMSD relative to the initial model, and color-coded for the fit to the EM map 
density. (C) Cartoon representation of our abMlaD hexameric model (magenta), superimposed to the crystallographic ecMlaD hexamer structure (grey). 

 

 


 !      	 	 	 	 	    	
	   	 !"       
 
   
 
   

 	     
     
  
 
       !"    
  
 
 
      
    
 
      
   

        !"       
 
     
   



Figure 2 - figure supplement 4. Close-up view of the MlaB, MlaD, MlaE and MlaF models in the abMlaBDEF cryo-EM map. (A) Region of the density corresponding to a MlaD 
monomer, with the corresponding atomic model in magenta. The density of the N-terminal helix is well resolved, as well as that of the A. baumannii-specific insert. (B) Region of the 
density corresponding to a MlaF-MlaB hetero-dimer, with the corresponding atomic models in green and cyan respectively, shown from two different angles. Density for helices are 
well defined for most of the model. (C) Region of the density corresponding to a MlaE monomer, with the corresponding atomic model in yellow. 
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Fig. 3. Localization of the 6 TM helices from MlaD. (A) lateral section of the abMlaBDEF EM map, with the MlaE model in yellow. Density attributed to the MlaD N-terminal helices are indicated with a red 
star. (B) 2D classes generated from the set of particles used to generate the MlaBDEFab structure, corresponding to side views. A range of orientations for the periplasmic domain is observed. (C) Structure of 
MlaBDEFab, generated using a subset of the most homogenious ~ 8,000 particles. Some features of the map shown in Figure 3C are not present, but the overall structure is similar. Six well- defined helices in 
the central TM region are visible. (D) Sections along the vertical axis, corresponding to the three red lines shown in B, is shown on the left. The six- fold axis of MlaD is visible in the periplasmic region, but this 
breaks down in the TM region, where the six helices are asymmetric. An angular representation of the six helices is represented on the right. 
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Figure 3 - figure supplement 1. Comparison of the MlaBDEF
ab
 and MalBDEF
ec
 complex. The map of MlaBDEFab (this study) is shown in grey, overlaid to that of 
MlaBDEFec (ekiert et al.) in yellow, aligned in the cytosolic domains density. The overall architecture of both complexes are similar, however MlaD appears offset by ~ 20 
O 
in the A. baumannii complex, compared to the E.coli complex. It remains to be determined if this corresponds to a difference between species, or if the two structures 
were obtained in different states of substrate binding and/or nucleotide hydrolysis.
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Fig 4. Outer membrane glycerophospholipid levels are reduced in ¨mlaC mutant. (A) Identification of inner and outer membrane phospholipids of wild type A. baumannii 
DQG¨mlaC using 2D thin-layer chromatography. PE, phosphatidylethanolamine; PG, phosphatidylglycerol; CL, cardiolipin. (B) LC-MS/MS quantification of isolated inner and outer 
membrane glycerophospholipids. Error bars indicate ± s.e.m. (n = 3). 
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Figure 4 - figure supplement 1. Purified periplasmic components of the Mla system remain bound to glycerophospholipids. (A) Chromatogram of 
LC-MS/MS of glycerophospholipids extracted from purified MlaC. Peaks were identified based on MS and elution time. PG, phosphatidylglycerol. PE, 
phosphatidylethanolamine. (B) Chromatogram of LC-MS/MS of glycerophospholipids extracted from purified MlaD soluble domain.
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Figure 4 - figure supplement 2. Deletion of mlaC results in a reduction in levels of outer membrane glycero-
phospholipids. Total ion scan of isolated outer membranes of A. baumanniiDQG¨mlaC. Typical membrane glycero-
phospholipids fall within the m/z range of 600-1500.
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Fig. 5. Newly synthesized glycerophospholipids accumulate at the inner membrane of Mla mutants. (A) LC-MS/MS quantification of 13C labelled/unlabeled glycerophospholipids in isolated membrane fractions over time after growth in 2-13&DFHWDWHLQ¨mlaF and complemented strain. Facet 
labels on the right indicate the specific glycerophospholipid species analyzed and the acyl chain length. PG, phosphatidylglycerol; PE, phosphatidylethanolamine. Shown is representative data from repeated experiments. Error bars represent ± s.d. (n = 2) for technical replicates. (B) LC-MS/MS 
quantification of 13C labelled/unlabeled glycerophospholipids in isolated membrane fractions following plasmid-based expression of MlaF compared to its dominant negative version, MlaFK55L. Facet labels on the right indicate the specific glycerophospholipid species analyzed and the acyl chain length. 
PG, phosphatidylglycerol; PE, phosphatidylethanolamine. Shown is representative data from repeated experiments. (C) Relative proportion of newly synthesized GPL on IM and OM after one hour growth in 2-13C acetate. Error bars represent ± s.d. (n = 2). Statistical analyses performed using a 
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Figure 5 - figure supplement 1. A stable isotope assay of glycerophospholipid transport from the inner membrane to the outer membrane (A) 
Schematic showing an example of the shift in mass-to-charge ratio (m/z) of glycerophospholipids (GPL) following growth in 2-13C acetate. (B) A schematic 
illustrating the rationale of the stable isotope assay: (1) Newly synthesized 13C-labeled GPL, shown here in red, are first inserted into the inner membrane (IM) 
following synthesis; (2) the likelihood that a given GPL that is trafficked from the IM to the OM will be labeled is proportional to the ratio of labeled to unlabeled GPL 
in the IM; (3) a comparison of the ratios of labeled to unlabeled GPL in the inner and outer membranes will therefore reflect the efficiency of GPL transport.  
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Figure 5 - figure supplement 2. Newly synthesized glycerophospholipids accumulate at the inner membrane of MlaA mutants. (A) LC-MS/MS quantification of 13C labelled/unlabeled glycerophospholipids in isolated membrane fractions over time after growth in 2-13C acetate 
LQ¨mlaC and complemented strain. Facet labels on the right indicate the specific glycerophospholipid species analyzed and the acyl chain length. PG, phosphatidylglycerol; PE, phosphatidylethanolamine. Shown is representative data from repeated experiments. (B) LC-MS/MS 
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Figrue 5 - figure supplement 3. Confirmation of inner and outer membrane separation. Each lane contains 10 µg total protein as measured by Bradford protein assay. (A) Ȭ-OmpA 
Western blot of separated membranes analyzed in Figure 4. (B) Ȭ-OmpA Western blot of separated membranes analyzed in Figure 5A (C) Ȭ-OmpA Western blot of separated 
membranes analyzed in Figure 5B. (D) Ȭ-OmpA Western blot of separated membranes analyzed in Figure 5C. (E) Coomasie stained SDS-protein gel of representative isolated 
membrane samples alongside BioRad Precision Plus Protein Standard. (F) Separation of inner and outer membranes into distinct bands by 3-step sucrose gradient. (G) NADH assay for 
enzymatic activity of inner membrane.
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Fig 6. The multicomponent Mla system transports glycerophospholipids from the inner membrane to the outer 
membrane of A. baumannii. A schematic of glycerophospholipid transport to the Gram-negative bacterial outer membrane 
by the Mla system.
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